A pharmaceutical composition for treating one or more symptoms of insomnia is disclosed herein. The pharmaceutical composition includes an amount of cannabidiol (CBD) and an amount of delta-9-tetrahydrocannabinol (THC), wherein the amount of CBD and the amount of THC are effective in treating insomnia. The pharmaceutical composition may include an amount of a selected herb and an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of chronic and acute pain using an amount of CBD and/or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of skin diseases and conditions using CBD and/or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid, an essential oil, a permeation enhancer, and/or an anti-bacterial/anti-viral agent.

A pharmaceutical composition for treating one or more symptoms of insomnia is disclosed herein. The pharmaceutical composition includes an amount of cannabidiol (CBD) and an amount of delta-9-tetrahydrocannabinol (THC), wherein the amount of CBD and the amount of THC are effective in treating insomnia. The pharmaceutical composition may include an amount of a selected herb and an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of chronic and acute pain using an amount of CBD and/or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid. A pharmaceutical composition for treating one or more symptoms of skin diseases and conditions using CBD and/or THC is also disclosed herein. The pharmaceutical composition may include an amount of another cannabinoid, an essential oil, a permeation enhancer, and/or an anti-bacterial/anti-viral agent.

The invention discloses a therapeutic topical composition, includes an extract of Galenia Africana having anti-microbial and anti-oxidant action. The composition includes rooibos and/or an extract from rooibos tea plant. The composition is adapted for regenerating skin, stimulating cyto-keratin production, treating human external fungal infections and/or conditions, human skin bacterial conditions, psoriasis, psoriasis plaque, dandruff, acne, bacterial acnes, eczema, athletes' foot, nappy rash, baby rash and/or lesions and/or being used for anti-septic wound treatment, and/or treating Propionibacterium acnes and/or staphylococcus epidermidis.

The invention discloses a therapeutic topical composition, includes an extract of Galenia Africana having anti-microbial and anti-oxidant action. The composition includes rooibos and/or an extract from rooibos tea plant. The composition is adapted for regenerating skin, stimulating cyto-keratin production, treating human external fungal infections and/or conditions, human skin bacterial conditions, psoriasis, psoriasis plaque, dandruff, acne, bacterial acnes, eczema, athletes' foot, nappy rash, baby rash and/or lesions and/or being used for anti-septic wound treatment, and/or treating Propionibacterium acnes and/or staphylococcus epidermidis.

The invention discloses a therapeutic topical composition, includes an extract of Galenia Africana having anti-microbial and anti-oxidant action. The composition includes rooibos and/or an extract from rooibos tea plant. The composition is adapted for regenerating skin, stimulating cyto-keratin production, treating human external fungal infections and/or conditions, human skin bacterial conditions, psoriasis, psoriasis plaque, dandruff, acne, bacterial acnes, eczema, athletes' foot, nappy rash, baby rash and/or lesions and/or being used for anti-septic wound treatment, and/or treating Propionibacterium acnes and/or staphylococcus epidermidis.

A method for treatment of viral infections, especially SARS-CoV-2 infections, said method comprising the administration of hydrolysable tannins.

A method of treating or inhibiting the symptoms of acute respiratory distress syndrome, especially that associated with Covid-19, said method comprising administering an effective amount of a cytokine and/or innate immune response modulating natural extract, its components or metabolites, or combinations thereof capable of modulating those cytokine and/or innate immune response associated mechanisms associated with acute respiratory distress.

A method of treating or inhibiting the symptoms of acute respiratory distress syndrome, especially that associated with Covid-19, said method comprising administering an effective amount of a cytokine and/or innate immune response modulating natural extract, its components or metabolites, or combinations thereof capable of modulating those cytokine and/or innate immune response associated mechanisms associated with acute respiratory distress.

The present invention discloses a cancer treatment method which includes the step of treating a patient having cancer with an extract from Galenia Africana L. plant. The extract may include pinocembrin and/or 2′,4′ dihydroxychalcone and/or 7-hydroxyflavanone. The cancer may be breast cancer or melanoma. The composition may be solubilized with MPG and/or Suganate.

The present invention discloses a cancer treatment method which includes the step of treating a patient having cancer with an extract from Galenia Africana L. plant. The extract may include pinocembrin and/or 2′,4′ dihydroxychalcone and/or 7-hydroxyflavanone. The cancer may be breast cancer or melanoma. The composition may be solubilized with MPG and/or Suganate.